CEACAM5 and colorectal carcinoma: There are several studies seeking to further evaluate the efficacy of CEA CAR T cells in CRC (NCT04513431, NCT05415475, NCT05396300), including specifically in refractory or relapsed cancer (NCT04348643) and metastatic disease (NCT05240950).